2023
Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial
Grilo C, Lydecker J, Jastreboff A, Pittman B, McKee S. Naltrexone/bupropion for binge‐eating disorder: A randomized, double‐blind, placebo‐controlled trial. Obesity 2023, 31: 2762-2773. PMID: 37751990, PMCID: PMC10600891, DOI: 10.1002/oby.23898.Peer-Reviewed Original ResearchConceptsNaltrexone/bupropionBinge-eating disorderObesity statusLogistic regressionWeight lossPlacebo-controlled trialWeight loss outcomesPrevalent psychiatric disordersEvidence-based treatmentsPost-treatment assessmentBinge-eating frequencyGreater percentage weight lossMedication outcomesRemission ratePharmacological optionsPlaceboBupropionPsychiatric disordersPercentage weight lossMixed modelsDisordersObesityPatientsSignificant reductionWeight reduction
2022
Using machine learning to predict heavy drinking during outpatient alcohol treatment
Roberts W, Zhao Y, Verplaetse T, Moore KE, Peltier MR, Burke C, Zakiniaeiz Y, McKee S. Using machine learning to predict heavy drinking during outpatient alcohol treatment. Alcohol Clinical And Experimental Research 2022, 46: 657-666. PMID: 35420710, PMCID: PMC9180421, DOI: 10.1111/acer.14802.Peer-Reviewed Original ResearchConceptsAlcohol use disorderHeavy drinkingTreatment outcomesInvasive assessment methodsOutpatient AUD treatmentLast monthOutpatient alcohol treatmentMultisite clinical trialAccurate clinical predictionsHeavy alcohol useSex differencesBi-weekly sessionsAlcohol treatment outcomesPatient characteristicsClinical outcomesClinical trialsClinical dataStratified analysisEffective treatmentPsychiatric disordersUse disordersAUD treatmentSubstantial sex differencesAlcohol treatmentFirst month
2019
Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III.
Moore KE, Oberleitner LMS, Zonana HV, Buchanan AW, Pittman BP, Verplaetse TL, Angarita GA, Roberts W, McKee SA. Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III. The Journal Of Clinical Psychiatry 2019, 80 PMID: 30758921, PMCID: PMC7826201, DOI: 10.4088/jcp.18m12317.Peer-Reviewed Original Research
2014
Crime and Psychiatric Disorders Among Youth in the US Population: An Analysis of the National Comorbidity Survey–Adolescent Supplement
Coker KL, Smith PH, Westphal A, Zonana HV, McKee SA. Crime and Psychiatric Disorders Among Youth in the US Population: An Analysis of the National Comorbidity Survey–Adolescent Supplement. Journal Of The American Academy Of Child & Adolescent Psychiatry 2014, 53: 888-898.e2. PMID: 25062596, PMCID: PMC4137504, DOI: 10.1016/j.jaac.2014.05.007.Peer-Reviewed Original ResearchConceptsNational Comorbidity Survey-Adolescent SupplementPsychiatric disordersPsychiatric comorbidityConduct disorderGreater oddsUS populationMental illnessDSM-IV-based diagnosisLifetime psychiatric disordersSpecific psychiatric disordersMental health servicesAlcohol use disorderRepresentative epidemiological sampleMore diagnosesUse disordersDrug useHealth servicesCommunity settingsLogistic regressionSimilar findingsDiagnosisEpidemiological sampleDisordersOddsSubstantial association
2012
Does co-morbid depression alter the inverse relationship between obesity and substance use disorders?
Gearhardt AN, Harrison EL, McKee SA. Does co-morbid depression alter the inverse relationship between obesity and substance use disorders? Drug And Alcohol Dependence 2012, 124: 185-188. PMID: 22285319, PMCID: PMC3359394, DOI: 10.1016/j.drugalcdep.2012.01.002.Peer-Reviewed Original ResearchConceptsSubstance use disordersCo-morbid depressionDrug use disordersUse disordersRisk factorsMajor depressionOverweight/obesity statusCommon risk factorsInverse relationshipNormal weightObesity statusExcess food consumptionPsychiatric disordersDepression disorderObesityDrug useReward circuitryU.S. adultsSubstance useDisordersDepressionAdultsFood consumptionRepresentative sampleCurrent study
2009
Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders
Weinberger AH, Desai RA, McKee SA. Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders. Drug And Alcohol Dependence 2009, 108: 7-12. PMID: 20006451, PMCID: PMC2835820, DOI: 10.1016/j.drugalcdep.2009.11.004.Peer-Reviewed Original ResearchConceptsSubstance use disordersCurrent mood disorderAlcohol use disorderCo-morbid psychiatric disordersTobacco withdrawal symptomsWithdrawal symptomsPsychiatric disordersMood disordersUse disordersNicotine withdrawalAnxiety disordersCurrent Axis I disordersCurrent daily smokersCurrent psychiatric disorderAxis I DisordersMore withdrawal symptomsWithdrawal-related symptomsNational Epidemiologic SurveyLogistic regression modelsPrevent relapseDaily smokersI disordersU.S. smokersAxis ICurrent disorder